ALGS (Aligos Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku

ALGS (Aligos Therapeutics) - tandha merek perusahaan

Aligos Therapeutics (ALGS) is implementing software automation to digitize clinical trial data. The annual EPS change on the GURU.Markets chart confirms the impact of these processes, with the value recorded at -174.60. Business prospects rely on the launch of drugs targeting hepatitis B and MASH. However, current stability remains low, as the company operates on shareholder investments.

ALGS (Aligos Therapeutics, Inc.) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 14.11.2026

Rincian metrik keuangan lan pasar aligos.com (ALGS)

- rega saham lan konsensus proyeksi valuasi:
Bagan rega Aligos Therapeutics, Inc.|ALGS - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Aligos Therapeutics, Inc.|ALGS - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Aligos Therapeutics|ALGS - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku aligos.com|ALGS - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Ekuitas Aligos Therapeutics|ALGS - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Aligos Therapeutics, Inc.|ALGS - Gunggung utang perusahaan|Utang marang aset resik Aligos Therapeutics, Inc.|ALGS - Utang jangka dawa perusahaan|Utang jangka cendhak Aligos Therapeutics|Koefisien jangkoan perantara aligos.com
- indikator pendapatan resik lan kelipatan nilai:
ALGS - Penghasilan resik|Penghasilan resik sing dikarepake Aligos Therapeutics|ALGS - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Aligos Therapeutics, Inc.|ALGS - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Aligos Therapeutics, Inc.|ALGS - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Aligos Therapeutics|ALGS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan aligos.com|ALGS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Aligos Therapeutics
- informasi babagan volume dodolan lan pendapatan:
ALGS - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan Aligos Therapeutics, Inc.|ALGS - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aligos Therapeutics, Inc.
Pambiji fundamental:ALGS (Aligos)
Produk dadi Aligos

The development of unique oligonucleotides for the elimination of hepatitis B creates potential for significant pricing power for Aligos Therapeutics (ALGS). Mathematically, this effect is reflected through the difference between current and previous year's net earnings per share. This metric measures the growth rate of return on equity, revealing the business's adaptation to market shocks. Investors assess the effectiveness of the strategy based on the annual change in earnings per share. The trend of this indicator confirms the company's ability to monetize inelastic demand.

Pesaing utama

ARWR (Arrowhead Pharma) - Wutah bathi saben saham ing taun lumaku|MIRM (Mirum Pharma) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku dynavax.com DVAX|Wutah bathi saben saham ing taun lumaku Arbutus Biopharma (ABUS)|IVA (inventivapharma.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku GYRE (Gyre Therapeutics)|Wutah bathi ing taun lumaku Assembly Bio ASMB|GALT - Wutah bathi saben saham ing taun lumaku|GNFT: Wutah bathi saben saham ing taun lumaku|DRRX: Wutah bathi ing taun lumaku|BIVI - Prakiraan wutah bathi resik saben saham ing taun iki|GLMD (Galmed Pharmaceuticals Ltd) - Wutah bathi ing taun lumaku|NDRA - Owah-owahan bathi resik saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Hepion Pharmaceuticals (HEPA)